Login
$MWAI
$0.37 +$0.10 (37.09%) Close

Consolidated balance sheets

In millions of USD, except per-share amounts
Q4 FY2026
As of Jun 30, 2026
Q3 FY2026
As of Mar 31, 2026
Q2 FY2026
As of Dec 31, 2025
Q1 FY2026
As of Sep 30, 2025
Q4 FY2025
As of Jun 30, 2025
Q3 FY2025
As of Mar 31, 2025
Q2 FY2025
As of Dec 31, 2024
Q1 FY2025
As of Sep 30, 2024
Q4 FY2024
As of Jun 30, 2024
Q3 FY2024
As of Mar 31, 2024
Q2 FY2024
As of Dec 31, 2023
Q1 FY2024
As of Sep 30, 2023
Q4 FY2023
As of Jun 30, 2023
Q3 FY2023
As of Mar 31, 2023
Q2 FY2023
As of Dec 31, 2022
Q1 FY2023
As of Sep 30, 2022
Q4 FY2022
As of Jun 30, 2022
Q3 FY2022
As of Mar 31, 2022
Q2 FY2022
As of Dec 31, 2021
Q1 FY2022
As of Sep 30, 2021
Current assets:
Cash
Cash
Receivables
Digital Assets
Prepaid expenses and other current assets
Deposits, Current
Current assets held for sale
Current assets of discontinued operations
Total current assets
Goodwill
Property and equipment, net
Digital currencies
Deposits
Intangible assets, net
Operating lease right-of-use assets
Deposits, noncurrent
Total non-current assets
Other assets of discontinued operations
Total other assets
TOTAL ASSETS
Accounts payable
Accrued expenses
Deferred revenue
Accrued preferred stock dividends
Series C Preferred Stock
Series D Preferred Stock
Total accrued preferred stock dividends
Operating lease liability, current
Due to related party
Notes payable in default, net of debt discount
Series C convertible preferred stock, $0.001 par value, 6,500 shares authorized, 6,500 shares issued and outstanding as of June 30, 2026
Current liabilities held for sale
Total current liabilities
Long Term Liabilities
Sub-lease security deposit
Sub-lease security deposit
Operating lease liability, long-term
Long term liabilities held for sale
Total Liabilities
Preferred stock, value
Series C Preferred Stock
Series D Preferred Stock
Commitments and contingencies
Stockholders' equity (deficit):
Common stock payable
Common stock, $0.001 par value, 300,000,000 shares authorized, 6,536,580 and 6,186,580 shares issued and outstanding as of June 30, 2026 and June 30, 2025, respectively
Additional paid in capital
Accumulated deficit
Total Stockholders' deficit of MedWellAI, Inc. and Subsidiaries
Noncontrolling interest
Total stockholders' deficit
Total liabilities, mezzanine and stockholders' deficit
Mezzanine equity
Series C Preferred Stock
Series D Preferred Stock
Preferred stock, value
Series C Preferred Stock
Series D Preferred Stock
Series B Preferred Stock
Series A Preferred Stock
Common stock payable

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support